Cutaneous reactions to chemotherapy drugs: the art of consultation.
Remlinger
Kathleen A
KA
Department of Dermatology, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL, USA. CPAMD@worldnet.att.net
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D000077143:Docetaxel; D004317:Doxorubicin / Q000009:adverse effects; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives*; D012867:Skin / Q000187:drug effects*; D043823:Taxoids; D013792:Thalidomide / Q000009:adverse effects
D000970:Antineoplastic Agents; D043823:Taxoids; D001761:Bleomycin; D000077143:Docetaxel; D013792:Thalidomide; D004317:Doxorubicin; D017239:Paclitaxel; D006918:Hydroxyurea